Santen Pharmaceutical Co., Ltd.
SNPHF
Price:
$10.53
Market Cap:
$522.67B
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in Phase III clinical trial to treat uveitis. Further, it offe...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2010-06-09
Stock Exchange
PNK
Ticker
SNPHF
PE Ratio
[22.89]
ROE
[8.82%]
Current Ratio
[2.60]
Dividend Yield
[2.16%]
Enterprise Value
[465.55B]
Dividend History
SNPHF Dividend History Overview
Dividends are a key part of long-term returns for investors, and Santen Pharmaceutical Co., Ltd. (SNPHF) has a track record worth reviewing. Looking at dividend history for SNPHF gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2025-03-28
Dividend Yield
2.16%
Annual Dividend
$0.11
P/E Ratio
22.89
Payout Ratio
0.45
Dividend per Share
$34.00
EPS
0.46
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2025-03-28 | $0.10817 | $0.10817 | 2025-06-01 | |
| 2024-09-27 | $0.117 | $0.117 | 2024-11-29 | |
| 2024-03-28 | $0.112 | $0.112 | ||
| 2023-09-28 | $0.10714 | $0.10714 | 2023-11-30 | |
| 2023-03-30 | $0.1205 | $0.1205 | 2023-06-28 | |
| 2022-09-29 | $0.111 | $0.11072 | 2022-11-30 | |
| 2022-03-30 | $0.13123 | $0.13123 | 2022-06-27 | |
| 2021-09-29 | $0.144 | $0.144 | 2021-11-30 | |
| 2021-03-30 | $0.12692 | $0.12692 | 2021-06-28 | |
| 2020-09-29 | $0.133 | $0.133 | 2020-11-30 | |
| 2020-03-30 | $0.12953 | $0.12953 | 2020-06-25 |
Santen Pharmaceutical Co., Ltd. (SNPHF) Dividend History Chart
The table below shows Santen Pharmaceutical Co., Ltd. (SNPHF) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Santen Pharmaceutical Co., Ltd. (SNPHF) Dividend Growth
Santen Pharmaceutical Co., Ltd. (SNPHF) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Ono Pharmaceutical Co., Ltd. (OPHLY) | 0.05% |
| GSK plc (GLAXF) | 0.05% |
| Pfizer Inc. (PFE) | 0.06% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Santen Pharmaceutical Co., Ltd. (SNPHF) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is SNPHF’s dividend yield?
What is the difference between regular and special dividends?
Has SNPHF increased its dividends over time?
Why might dividend history data be delayed?
How often does SNPHF pay dividends?
What factors impact SNPHF's dividend payments?
Can dividends change over time?
What is SNPHF’s next dividend date?